ELIZABETH MILLER: Open Payments
NPI 1932654142 · BROWNWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$306 in 16 payments from 8 companies in 2025. Trend: 2023 $538 · 2024 $510 · 2025 $306
Food & beverage: $306
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| PFIZER INC. | 2 | $48 |
| ABBVIE INC. | 2 | $35 |
| Exact Sciences Corporation | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
Products named: FARXIGA, ELIQUIS, Rybelsus, Ozempic, QULIPTA, Cologuard Collection Kit, REXULTI, Veozah.
Industry payments across TX — which companies pay providers there.
